Comparison of International Normalized Ratios provided by two point-of-care devices and laboratory-based venipuncture in a pharmacist-managed anticoagulation clinic

American Journal of Health-System Pharmacy

Volumn 67, Issue 19, 2010, Pages 1616-1622

  Donaldson, Mark ^a,b   Sullivan, John ^c   Norbeck, Amber ^c  

^a KALISPELL REGIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c KRMC   (United States)

Author keywords

Ambulatory care; Anticoagulants; Equipment; International normalized ratio; Laboratory; Methodology; Pharmacists; Tests; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PRIORITY JOURNAL; VEIN PUNCTURE; COMPARATIVE STUDY; DRUG MONITORING; HOSPITAL INFORMATION SYSTEM; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PHARMACIST; PROFESSIONAL STANDARD; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ANTICOAGULANTS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHARMACISTS; POINT-OF-CARE SYSTEMS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; WARFARIN;

EID: 79952111488     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100096     Document Type: Article

References (27)

1. Zimmerman CR. The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders. J Thromb Thrombolysis. 2000; 9:187-98. (Pubitemid 30201249)
2. Finck KM, Doetkott C, Miller DR. Clinical impact of interlaboratory variation in International Normalized Ratio determinations. Am J Health-Syst Pharm. 2001; 58:684-8. (Pubitemid 32319367)
3. Dorfman DM, Goonan EM, Boutilier MK et al. Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med. 2005; 10:23-7. (Pubitemid 40667582)
4. Havrda DE, Hawk TL, Marvin CM. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic. Ann Pharmacother. 2002; 36:769-75. (Pubitemid 34517403)
5. Moore GW, Henley A, Cotton SS et al. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting. Blood Coagul Fibrinolysis. 2007; 18:287-92. (Pubitemid 46597404)
6. Jacobson AK, Ruybalid RL, Johnston M et al. Significant variation in the reporting of prothrombin time results despite utilization of the INR method of reporting. Circulation. 1999; 100:I-620. Abstract.
7. Hirsh J, Guyett G, Albers G et al. The Seventh ACCP Consensus Conference on Antithrombotic Therapy and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004; 126(suppl):172S-3S.
8. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J. 1996; 132:1095-100. (Pubitemid 26372785)
9. Nutescu EA. The future of anticoagulation clinics. J Thromb Thrombolysis. 2003; 16:61-3. (Pubitemid 38477225)
10. Witte K, Gurwich EL, Anzalone R et al. Audit of an oral anticoagulant teaching program. Am J Hosp Pharm. 1980; 37:89-91. (Pubitemid 10175473)
11. Griffin BL, Burkiewicz JS, Peppers LR et al. International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic. Am J Health-Syst Pharm. 2009; 66:1218-23.
12. Bungard TJ, Gardner L, Archer SL et al. Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care. Open Med. 2009; 3:e16-e21.
13. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998; 158:1641-7. (Pubitemid 28371187)
14. Kaatz SS, White RH, Hill J et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med. 1995; 155:1861-7.
15. Reed C, Rickman H. Accuracy of International Normalized Ratio determined by portable whole-blood coagulation monitor versus a central laboratory. Am J Health-Syst Pharm. 1999; 56:1619-23. (Pubitemid 29395151)
16. Chapman DC, Stephens MA, Hamann GL et al. Accuracy, clinical correlation, and patient acceptance of two hand-held prothrombin time monitoring devices in the ambulatory setting. Ann Pharmacother. 1999; 33:775-80. (Pubitemid 29387652)
17. Lassen JF, Brandslund I, Antonsen S. International Normalized Ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurement. Clin Chem. 1995; 41:444-7.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307-10. (Pubitemid 16134762)
19. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8:135-60. (Pubitemid 29425900)
20. Gosselin R, Owings JT, White RH et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost. 2000; 83:698-703. (Pubitemid 30248517)
21. Van den Besselar AM. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost. 2000; 84:410-2.
22. Kemme MJ, Faaij RA, Schoemaker RC et al. Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants. Blood Coagul Fibrinolysis. 2001; 12:583-91. (Pubitemid 33022524)
23. Grasso-Correnti N, Goldszer RC, Goldhaber SZ. The critical pathways of an anticoagulation service. Crit Pathw Cardiol. 2003; 2:41-5. (Pubitemid 37465940)
24. Palareti G, Manotti C, D'Angelo A et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study. ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost. 1997; 78:1438-43. (Pubitemid 27519386)
25. Poller L, Keown M, Chauhan N et al. European Concerted Action on Anticoagulation (ECAA): an assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT. J Thromb Haemost. 2002; 1:766-72.
26. Poller L, Keown M, Chauhan N et al. European Concerted Action on Anticoagulation: comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors. Thromb Haemost. 2002; 87:859-66. (Pubitemid 34516615)
27. Hirsh J, Dalen JE, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001; 119(suppl):8S-21S.